SeekingAlpha · Oct 30, 2026
Gilead Sciences: Why I Remain Bullish After Q3
Gilead Sciences had a strong Q3, while successfully shifting its R&D focus from HIV to the immunology market. Read why GILD stock is a buy.
IP
OTC · IPSEY
Ipsen S.A.
Healthcare · Drug Manufacturers - Specialty & Generic
$43.67
Down-$0.05 (-0.12%)
Updated Nov 4, 2026, 11:02 PM
SID Score
6.7/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 47.01B
- P/E ratio
- 22.47
- Dividend yield
- 0.91%
- 52-week range
- $25.11 – $51.10
- Volume
- 426
- Avg. volume
- 1.58K
Price performance · IPSEY
IPSEY price history
1M range · 14 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
IPSEY closed at $43.72 after 14 trading sessions, up 9.60% for the selected period.
- Last close
- $43.72
- Period change
- +9.60%
- Period low
- $39.89
- Period high
- $44.46
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $43.72 | $43.72 | $43.72 | $43.72 | 426 |
| Nov 2, 2026 | $44.00 | $44.28 | $43.762 | $44.28 | 1.22K |
| Oct 30, 2026 | $43.89 | $44.4613 | $43.89 | $44.4613 | 458 |
| Oct 29, 2026 | $44.3538 | $44.3538 | $44.3538 | $44.3538 | 556 |
| Oct 28, 2026 | $42.01 | $42.01 | $42.01 | $42.01 | 9.29K |
| Oct 27, 2026 | $42.25 | $42.75 | $42.25 | $42.60 | 13.21K |
| Oct 26, 2026 | $42.50 | $43.56 | $42.50 | $43.56 | 2.8K |
| Oct 23, 2026 | $43.85 | $43.85 | $43.85 | $43.85 | 1.18K |
| Oct 21, 2026 | $42.996 | $42.996 | $42.996 | $42.996 | 341 |
| Oct 15, 2026 | $40.93 | $40.93 | $40.93 | $40.93 | 327 |
| Oct 14, 2026 | $40.00 | $40.00 | $40.00 | $40.00 | 1.13K |
| Oct 9, 2026 | $40.654 | $40.654 | $40.654 | $40.654 | 395 |
| Oct 8, 2026 | $39.12 | $40.15 | $39.12 | $40.15 | 16.35K |
| Oct 6, 2026 | $39.8265 | $39.89 | $39.8265 | $39.89 | 2.46K |
Latest IPSEY news
The latest Smart Investors Daily articles mentioning IPSEY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
IPSEY research
Overview
Company profile and research snapshot.
Company profile
IPSEN SA S/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 6
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 20, 2026 | JEFFERIES | Underperform | — |
| Sep 18, 2026 | BAADER EUROPE / ALPHAVALUE | Buy | — |
| Aug 31, 2026 | BNP PARIBAS | Neutral | — |
| Aug 4, 2026 | ESN/CIC MARKET SOLUTIONS | Buy | — |
| Aug 4, 2026 | ROTHSCHILD & CO REDBURN | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 22, 2026
Ipsen delivers outstanding sales growth in the first nine months of 2026 and further upgrades its full-year guidance
Year-to-date total sales growth of 24.6% at CER1, or 23.0% as reported, with the core portfolio2 achieving sales growth of 24.2%1 Further upgraded FY 2026 financial guidance: total sales growth around 23.0% at CER (prior guidance: greater than 20.0% at CER); core operating margin around 39.0% of total sales (prior guidance: greater than 37.0%) Multiple late-stage pipeline assets with blockbuster potential in Oncology, Rare Disease and Neuroscience, strengthening Ipsen's future growth profile PAR
Yahoo · Oct 7, 2026
Ipsen - September 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights (1)30 September 202683,814,526Gross total* of voting rights: 132,065,045Net total**
Yahoo · Sep 28, 2026
IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2026
Aggregated presentation by day and by market Weekly report on share repurchases from 21st September to 22nd September 2026 Name of the IssuerIdentify code of the IssuerTransaction dayIdentify code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1121/09/2026FR001025915021 158146,4614XPARIPSEN549300M6SGDPB4Z94P1121/09/2026FR00102591507 870146,0726CEUXIPSEN549300M6SGDPB4Z94P1121/09/2026FR00
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
